Table A2.
Study | Random Sequence Generation | Allocation Concealment | Blinding Patients/Personel | Blinding Outcome Assess | Incomplete Outcome | Select Reporting | Other Bias | Overall Jadad [0–5] | ||
---|---|---|---|---|---|---|---|---|---|---|
Bendel, 1988 [20] | + | + | - | - | + | + | + | 2 | - | =High Risk |
Bendel, 1989 [19] | ? | + | - | - | + | + | + | 1 | ||
Bräunig, 1992 [36] | ? | ? | ? | ? | + | - | + | 1 | + | =Low Risk |
Cohen, 2004 [18] | + | + | + | + | ? | + | + | 4 | ||
Forth, 1981 [17] | + | - | - | ? | ? | - | ? | 1 | ? | =Unclear |
Freyer, 1974 [22] | + | - | - | - | + | + | + | 1 | ||
Goel, 2004 [38] | + | + | + | + | + | + | + | 5 | ||
Grimm, 1996 [23] | + | ? | + | + | + | + | + | 5 | ||
Hall, 2007 [24] | + | + | + | + | ? | ? | + | 4 | ||
Helbig, 1961 [25] | ? | - | - | - | + | + | + | 1 | ||
Jawad, 2012 [26] | + | + | + | + | ? | ? | + | 5 | ||
Kolev, 2022 [27] | + | - | - | + | + | + | + | 2 | ||
Berg, 1998 [21] | ? | + | + | ? | + | + | + | 3 | ||
Melchart, 1998 [15] | + | + | - | ? | + | + | + | 4 | ||
Ogal, 2021 [14] | + | + | ? | + | + | + | + | 5 | ||
O’Neil, 2008 [28] | + | + | + | + | - | + | + | 4 | ||
Osama 2020 [29] | + | + | - | - | - | + | ? | 1 | ||
Raus, 2015 [39] | + | + | + | + | + | + | + | 5 | ||
Schmidt 1990 [30] | ? | + | ? | ? | + | + | + | 4 | ||
Schulten, 2001 [40] | + | - | + | + | + | ? | + | 3 | ||
Spasov, 2004 [41] | + | - | - | - | ? | ? | ? | 2 | ||
Sperber, 2004 [31] | ? | ? | + | + | + | + | + | 3 | ||
Sumer, 2023 [37] | + | + | ? | ? | + | + | + | 4 | ||
Taylor03-Weber05 [35,42] | + | + | + | + | + | + | + | 5 | ||
Tiralongo, 2012 [32] | + | + | + | + | ? | + | + | 5 | ||
Turner, 2000 [33] | ? | ? | ? | + | + | + | + | 3 | ||
Turner, 2005 [16] | + | ? | + | + | + | + | + | 4 | ||
Yakoot, 2011 [43] | + | + | + | + | + | ? | + | 5 | ||
Zhang, 2003 [34] | + | + | - | - | ? | + | + | 3 |